https://www.businesswire.com/news/home/20191222005030/en/ > TORONTO--(BUSINESS WIRE)--Dec 23, 2019-- > Halo Labs Inc. (“ Halo ” or the “ Company ”) (NEO:HALO, OTCQX:AGEEF, Germany:A9KN) is pleased to announce that it has entered into a definitive agreement (the “Agreement”) to acquire all of the common shares of Precisa Medical Instruments Corp. (“Precisa”) for C$3,750,000 in Halo common shares at a price of C$0.28 per share (“the Acquisition”).